| # | Drug | Count |
|---|---|---|
| 0 | ADALIMUMAB | 54 |
| 1 | PREDNISONE | 44 |
| 2 | METHOTREXATE SODIUM | 41 |
| 3 | METHOTREXATE | 37 |
| 4 | INFLIXIMAB | 35 |
| 5 | ETANERCEPT | 32 |
| 6 | RIBAVIRIN | 32 |
| 7 | HYDROXYCHLOROQUINE | 24 |
| 8 | ADALIMUMAB-AATY | 22 |
| 9 | ADALIMUMAB-ADAZ | 22 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | CALCIPOTRIENE AND BETAMETHASONE DIPROPIONATE | 7 | 0.0021 |
| 1 | SORBITOL | 1 | 0.0017 |
| 2 | COBIMETINIB | 6 | 0.0014 |
| 3 | TRANDOLAPRIL TABLETS | 2 | 0.0010 |
| 4 | IMIQUIMOD | 2 | 0.0009 |
| 5 | HYALURONIC ACID | 1 | 0.0009 |
| 6 | OLMESARTAN MEDOXOMIL / AMLODIPINE BESYLATE / HYDROCHLOROTHIAZIDE | 1 | 0.0008 |
| 7 | DABRAFENIB | 16 | 0.0008 |
| 8 | TALIMOGENE LAHERPAREPVEC | 1 | 0.0006 |
| 9 | EPIRUBICIN HYDROCHLORIDE | 4 | 0.0006 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Interleukin-5 Antagonist [EPC] | 2 | 0.0029 |
| 1 | Adrenocorticotropic Hormone [EPC] | 2 | 0.0022 |
| 2 | Interleukin-17A Antagonist [EPC] | 16 | 0.0004 |
| 3 | Programmed Death Receptor-1 Blocking Antibody [EPC] | 38 | 0.0004 |
| 4 | Nucleoside Analog Antiviral [EPC] | 32 | 0.0004 |
| 5 | Bismuth [EPC] | 2 | 0.0004 |
| 6 | CTLA-4-directed Blocking Antibody [EPC] | 10 | 0.0002 |
| 7 | CD52-directed Cytolytic Antibody [EPC] | 4 | 0.0002 |
| 8 | Gadolinium-based Contrast Agent [EPC] | 1 | 0.0002 |
| 9 | Programmed Death Ligand-1 Blocker [EPC] | 4 | 0.0002 |